First, we used whole-cell patch clamp electrophysiology to investigate the effect of removing PIP2 on TRPC3 activity, using the direct and non- lipid activator GSK1702934A (GSK17; Fig. 1b–d). Application of GSK allows us to activate TRPC3 while bypassing the PLC pathway, which results ...